Cat Medicines Market by Product Type, Health Condition, Route Of Administration - Global Forecast 2025-2030- Product Image

Sale

Cat Medicines Market by Product Type, Health Condition, Route Of Administration - Global Forecast 2025-2030

Report
184 Pages
October 2024
Region: Global
360iResearch™
ID: 6011229

UP TO €684EUR$697USD£571GBP OFF until Dec 31^st 2024

The Cat Medicines Market grew from USD 15.35 billion in 2023 to USD 16.12 billion in 2024. It is expected to continue growing at a CAGR of 6.31%, reaching USD 23.56 billion by 2030.

The cat medicines market encompasses therapies and pharmaceuticals specifically designed for cat health, including treatments for common ailments, preventive care, and chronic conditions. This sector addresses the necessity of maintaining pet health due to rising pet adoption rates, which are fueled by growing humanization of pets and the increasing regard for pets as family members. The primary application spans antibiotics, vaccines, anti-parasitic drugs, and specialized medication for conditions like diabetes and arthritis, targeting veterinarians, pet owners, and veterinary clinics as key end-users. Influencing these dynamics are advancements in veterinary technology, heightened awareness of pet healthcare, and an upsurge in chronic diseases among cats, thereby driving demand. Moreover, the COVID-19 pandemic has heightened pet adoption, subsequently boosting market growth due to increased health management needs. A pivotal opportunity lies in personalized medications and preventive treatments, as advances in genomics and data analytics offer paths for tailored healthcare solutions. Companies can capitalize on these by investing in R&D and forging strategic partnerships with biotech firms. Yet, challenges such as regulatory barriers, high development costs of pharmaceuticals, and competition from generics and natural remedies impede market progress. Additionally, the fluctuating economic conditions can bear on owners' ability to afford premium treatments. Best channels for innovation include formulating non-invasive treatments, developing nutraceuticals, and utilizing digital health platforms for management and diagnosis. Businesses should focus on creating comprehensive care solutions that integrate wellness with routine healthcare. The market remains dynamic, driven by a combination of technological innovation, increased consumer spending on pet health, and shifts in consumer preferences towards sustainability and natural products. Leveraging data-driven insights, enhancing distribution networks, and focusing on consumer education could unlock substantial growth avenues in this niche market.

Understanding Market Dynamics in the Cat Medicines Market

The Cat Medicines Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Expansion of online veterinary pharmacy services making cat medicines more accessible
- Government regulations favoring pet health and safety standards influencing market growth
- Increase in pet insurance policies covering expenses for cat treatments driving market demand
- Development of innovative drug delivery systems for easier administration of cat medications
Market Restraints
- Limited consumer awareness about the importance of regular veterinary care for cats especially in developing regions
- Stringent regulatory requirements for the approval and commercialization of new cat medications limiting product availability
Market Opportunities
- Innovative cat health supplements targeting holistic wellness in the pet care market
- Advanced prescription medications for common feline illnesses with proven higher efficacy rates
- Sustainable and eco-friendly cat medications aiming at environmental-conscious pet owners
Market Challenges
- Concerns over drug efficacy and side effects affect market adoption

Exploring Porter’s Five Forces for the Cat Medicines Market

Porter’s Five Forces framework further strengthens the insights of the Cat Medicines Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cat Medicines Market

External macro-environmental factors deeply influence the performance of the Cat Medicines Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cat Medicines Market

The Cat Medicines Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cat Medicines Market

The Cat Medicines Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cat Medicines Market

The Cat Medicines Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cat Medicines Market, highlighting leading vendors and their innovative profiles. These include Aratana Therapeutics, Archer Daniels Midland Company, Bayer Animal Health, Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals, Elanco Animal Health, Heska Corporation, Hill's Pet Nutrition (Colgate-Palmolive), IDEXX Laboratories, Kindred Biosciences, Merck Animal Health, MWI Animal Health, Nestle Purina PetCare, PetIQ, Phibro Animal Health, Royal Canin, Vetoquinol, Virbac, and Zoetis.

Market Segmentation & Coverage

This research report categorizes the Cat Medicines Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
- Non-Prescription Medicines
  - First Aid Products
  - Herbal Remedies
  - Nutritional Supplements
  - Over-The-Counter Pain Relief
  - Topical Treatments
- Prescription Medicines
  - Anti-Inflammatory Drugs
  - Antibiotics
  - Hormonal Drugs
  - Pain Relievers
  - Vaccines
Health Condition
- Digestive Health
  - Fiber Supplements
  - Probiotics
- Immune System Support
  - Antioxidants
- Joint Health
  - Glucosamine
- Skin and Coat Health
  - Allergy Relief
  - Omega Fatty Acids
Route Of Administration
- Injectable
  - Vaccines
- Oral
  - Liquids
  - Tablets
- Topical
  - Creams
  - Sprays
- Transdermal
  - Patches

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expansion of online veterinary pharmacy services making cat medicines more accessible
5.1.1.2. Government regulations favoring pet health and safety standards influencing market growth
5.1.1.3. Increase in pet insurance policies covering expenses for cat treatments driving market demand
5.1.1.4. Development of innovative drug delivery systems for easier administration of cat medications
5.1.2. Restraints
5.1.2.1. Limited consumer awareness about the importance of regular veterinary care for cats especially in developing regions
5.1.2.2. Stringent regulatory requirements for the approval and commercialization of new cat medications limiting product availability
5.1.3. Opportunities
5.1.3.1. Innovative cat health supplements targeting holistic wellness in the pet care market
5.1.3.2. Advanced prescription medications for common feline illnesses with proven higher efficacy rates
5.1.3.3. Sustainable and eco-friendly cat medications aiming at environmental-conscious pet owners
5.1.4. Challenges
5.1.4.1. Concerns over drug efficacy and side effects affect market adoption
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Cat Medicines Market, by Product Type

6.1. Introduction
6.2. Non-Prescription Medicines
6.2.1. First Aid Products
6.2.2. Herbal Remedies
6.2.3. Nutritional Supplements
6.2.4. Over-The-Counter Pain Relief
6.2.5. Topical Treatments
6.3. Prescription Medicines
6.3.1. Anti-Inflammatory Drugs
6.3.2. Antibiotics
6.3.3. Hormonal Drugs
6.3.4. Pain Relievers
6.3.5. Vaccines

7. Cat Medicines Market, by Health Condition

7.1. Introduction
7.2. Digestive Health
7.2.1. Fiber Supplements
7.2.2. Probiotics
7.3. Immune System Support
7.3.1. Antioxidants
7.4. Joint Health
7.4.1. Glucosamine
7.5. Skin and Coat Health
7.5.1. Allergy Relief
7.5.2. Omega Fatty Acids

8. Cat Medicines Market, by Route Of Administration

8.1. Introduction
8.2. Injectable
8.2.1. Vaccines
8.3. Oral
8.3.1. Liquids
8.3.2. Tablets
8.4. Topical
8.4.1. Creams
8.4.2. Sprays
8.5. Transdermal
8.5.1. Patches

9. Americas Cat Medicines Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Cat Medicines Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Cat Medicines Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

LIST OF FIGURES

FIGURE 1. CAT MEDICINES MARKET RESEARCH PROCESS
FIGURE 2. CAT MEDICINES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CAT MEDICINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CAT MEDICINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CAT MEDICINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CAT MEDICINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CAT MEDICINES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CAT MEDICINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. CAT MEDICINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CAT MEDICINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CAT MEDICINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CAT MEDICINES MARKET DYNAMICS
TABLE 7. GLOBAL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CAT MEDICINES MARKET SIZE, BY FIRST AID PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CAT MEDICINES MARKET SIZE, BY HERBAL REMEDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CAT MEDICINES MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CAT MEDICINES MARKET SIZE, BY OVER-THE-COUNTER PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CAT MEDICINES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CAT MEDICINES MARKET SIZE, BY HORMONAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CAT MEDICINES MARKET SIZE, BY PAIN RELIEVERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CAT MEDICINES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CAT MEDICINES MARKET SIZE, BY FIBER SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CAT MEDICINES MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CAT MEDICINES MARKET SIZE, BY ANTIOXIDANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CAT MEDICINES MARKET SIZE, BY GLUCOSAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CAT MEDICINES MARKET SIZE, BY ALLERGY RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CAT MEDICINES MARKET SIZE, BY OMEGA FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CAT MEDICINES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CAT MEDICINES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CAT MEDICINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CAT MEDICINES MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CAT MEDICINES MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CAT MEDICINES MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CAT MEDICINES MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CAT MEDICINES MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 92. CANADA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. CANADA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 94. CANADA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 95. CANADA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 96. CANADA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 97. CANADA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 98. CANADA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 99. CANADA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 100. CANADA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 101. CANADA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 102. CANADA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 103. CANADA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 104. CANADA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 105. MEXICO CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. MEXICO CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 107. MEXICO CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 108. MEXICO CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 109. MEXICO CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 110. MEXICO CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 111. MEXICO CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 112. MEXICO CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 113. MEXICO CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. MEXICO CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 115. MEXICO CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 116. MEXICO CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 117. MEXICO CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES CAT MEDICINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 159. CHINA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. CHINA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 161. CHINA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 162. CHINA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 163. CHINA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 164. CHINA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 165. CHINA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 166. CHINA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 167. CHINA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 168. CHINA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 169. CHINA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 170. CHINA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 171. CHINA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 172. INDIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. INDIA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 174. INDIA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 175. INDIA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 176. INDIA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 177. INDIA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 178. INDIA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 179. INDIA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 180. INDIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. INDIA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 182. INDIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 183. INDIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 184. INDIA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 198. JAPAN CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. JAPAN CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 200. JAPAN CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 201. JAPAN CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 202. JAPAN CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 203. JAPAN CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 204. JAPAN CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 205. JAPAN CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 206. JAPAN CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. JAPAN CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 208. JAPAN CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 209. JAPAN CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 210. JAPAN CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 224. PHILIPPINES CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. PHILIPPINES CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 226. PHILIPPINES CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 227. PHILIPPINES CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 228. PHILIPPINES CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 229. PHILIPPINES CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 230. PHILIPPINES CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 237. SINGAPORE CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. SINGAPORE CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 239. SINGAPORE CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 240. SINGAPORE CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 241. SINGAPORE CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 242. SINGAPORE CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 243. SINGAPORE CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 250. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 252. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 253. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 254. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 255. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 256. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 259. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 260. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 261. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 262. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 263. TAIWAN CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. TAIWAN CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 265. TAIWAN CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 266. TAIWAN CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 267. TAIWAN CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 268. TAIWAN CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 269. TAIWAN CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 276. THAILAND CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. THAILAND CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 278. THAILAND CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 279. THAILAND CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 280. THAILAND CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 281. THAILAND CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 282. THAILAND CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 283. THAILAND CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 284. THAILAND CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 285. THAILAND CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 286. THAILAND CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 287. THAILAND CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 288. THAILAND CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 289. VIETNAM CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. VIETNAM CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 291. VIETNAM CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 292. VIETNAM CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 293. VIETNAM CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 294. VIETNAM CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 295. VIETNAM CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 296. VIETNAM CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 297. VIETNAM CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 298. VIETNAM CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 299. VIETNAM CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 300. VIETNAM CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 301. VIETNAM CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 316. DENMARK CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. DENMARK CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 318. DENMARK CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 319. DENMARK CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 320. DENMARK CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 321. DENMARK CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 322. DENMARK CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 323. DENMARK CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 324. DENMARK CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 325. DENMARK CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 326. DENMARK CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 327. DENMARK CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 328. DENMARK CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 329. EGYPT CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 330. EGYPT CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 331. EGYPT CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 332. EGYPT CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 333. EGYPT CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 334. EGYPT CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 335. EGYPT CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 336. EGYPT CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 337. EGYPT CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 338. EGYPT CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 339. EGYPT CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 340. EGYPT CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 341. EGYPT CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 342. FINLAND CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 343. FINLAND CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 344. FINLAND CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 345. FINLAND CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
TABLE 346. FINLAND CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 347. FINLAND CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
TABLE 348. FINLAND CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 349. FINLAND CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
TABLE 350. FINLAND CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 351. FINLAND CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 352. FINLAND CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 353. FINLAND CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 354. FINLAND CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 355. FRANCE CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 356. FRANCE CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
TABLE 357. FRANCE CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD

Companies Mentioned

The leading players in the Cat Medicines market, which are profiled in this report, include:

Aratana Therapeutics
Archer Daniels Midland Company
Bayer Animal Health
Boehringer Ingelheim
Ceva Santé Animale
Dechra Pharmaceuticals
Elanco Animal Health
Heska Corporation
Hill's Pet Nutrition (Colgate-Palmolive)
IDEXX Laboratories
Kindred Biosciences
Merck Animal Health
MWI Animal Health
Nestle Purina PetCare
PetIQ
Phibro Animal Health
Royal Canin
Vetoquinol
Virbac
Zoetis

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 16.12 Billion
Forecasted Market Value ( USD ) by 2030	$ 23.56 Billion
Compound Annual Growth Rate	6.3%
Regions Covered	Global
No. of Companies Mentioned	21

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3481EUR$3,545USD£2,904GBP €3868EUR$3,939USD£3,227GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6158EUR$6,272USD£5,138GBP €6843EUR$6,969USD£5,709GBP

Understanding Market Dynamics in the Cat Medicines Market

Exploring Porter’s Five Forces for the Cat Medicines Market

Applying PESTLE Analysis to the Cat Medicines Market

Analyzing Market Share in the Cat Medicines Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cat Medicines Market

Strategic Recommendations for Success in the Cat Medicines Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Veterinary Medicine Market Size, Share & Trends Analysis Report by Product (Biologics, Pharmaceuticals, Medicated Feed Additives), Animal Type, Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030

Cat Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type (Inactivated), Disease Type, Route of Administration, Duration of Immunity, Component, Region, and Segment Forecasts, 2024-2030

Veterinary Dermatology Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Companion Animal Ear Infection Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Pet Obesity Management Market by Animal Type, Diet Type, Treatment Type, End Users, Solutions, Pet Age - Global Forecast 2025-2030